Skip to main content
OpenTrials

Clinical trial condition

Carcinoid Tumor

Explore clinical trials studying Carcinoid Tumor. Study availability and eligibility vary by location and protocol.

67 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Carcinoid Tumor trial results

Completed

Chromogranin A as Blood Marker in Cancer Patients

NCT03817866

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +25 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Charité - Universitätsmedizin Berlin Berlin, Germany
View Trial Details
Completed

An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome

NCT00774930

Conditions
Adenocarcinoma, Carcinoid Syndrome, Carcinoid Tumor, +17 more
Locations
  • VA Greater Los Angeles Health Care System Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Cedars Sinai Outpatient Cancer Center West Hollywood, California, United States
View all 54 locations
View Trial Details
Completed

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

NCT01789281

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +7 more
Locations
  • Hematology Oncology Services of Arkansas SC Little Rock, Arkansas, United States
  • Rocky Mountain Cancer Centers SC Greenwood Village, Colorado, United States
  • Stamford Hospital Stamford, Connecticut, United States
  • H Lee Moffitt Cancer Center and Research Institute SC-2 Tampa, Florida, United States
View all 24 locations
View Trial Details
Completed

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

NCT01327612

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +44 more
Locations
  • Research Site Duarte, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Tampa, Florida, United States
View Trial Details
Completed

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

NCT00446082

Conditions
Acromegaly, Adenocarcinoma, Bone Diseases, +18 more
Locations
  • Cedars Sinai Medical Center SC - 4 Los Angeles, California, United States
  • Stanford University Medical Center Stanford Cancer Center (3) Stanford, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Dept.of H.LeeMoffittCC&RI(1) Tampa, Florida, United States
  • University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology Houston, Texas, United States
View all 17 locations
View Trial Details
Completed

A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer

NCT00781911

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +19 more
Locations
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Aurora, Colorado, United States
  • ImClone Investigational Site Atlanta, Georgia, United States
View Trial Details

Related conditions